Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Henlius Strengthens Collaboration with Intas to Bring Novel Anti-PD-1 mAb Serplulimab to Europe and India
Saturday, October 28, 2023Shanghai Henlius Biotech Inc has recently entered an exclusive licensing agreement with Intas Pharmaceuticals Limited for the development and commercialization of multiple indications including ESSCLC
Biosyngen's BST02 Secures FDA Approval for Investigational New Drug (IND) in Liver Cancer TIL Therapy, a Historic Milestone
Friday, October 27, 2023Biosyngen has received approval from the US FDA to conduct clinical trials for their TIL therapy BST aimed at treating liver cancer This therapy is a groundbreaking advancement in cell and gene therapy
Everest Medicines Receives Approval from the Pharmaceutical Administration Bureau of Macau for Nefecon® in the Treatment of Primary IgA Nephropathy
Friday, October 27, 2023Everest Medicines a biopharmaceutical company dedicated to developing manufacturing and distributing innovative medicines and vaccines has announced that the Pharmaceutical
The Phase 3 Clinical Trial for First-Line LS-SCLC Utilizing Henlius' Anti-PD-1 mAb Serplulimab Begins Patient Dosing in Europe
Thursday, October 26, 2023Shanghai Henlius Biotech Inc recently commenced a phase clinical trial for their proprietary antiPD monoclonal antibody in combination with chemotherapy and concurrent radiotherapy for patients
Medicenna Therapeutics Administers Initial Dose in Phase 2 Monotherapy Dose Expansion Component of ABILITY Study for Assessment of MDNA11 in Specific Solid Tumor Varieties
Thursday, October 26, 2023Medicenna Therapeutics Corp has made an important announcement regarding its clinicalstage immunotherapy program The company has initiated the dosing of the first patient in the Phase monotherapy dose expansion
BioRay Pharmaceutical's BR105 Injection Clinical Trial Application (IND) Secures U.S. FDA Approval
Wednesday, October 25, 2023BioRay Pharmaceutical Co Ltd made a significant announcement on October th They shared that their clinical trial application for BR Injection has received approval from the United States Food and Drug Administration
Liantuo Biotech and Bristol-Myers Squibb Enter Into Agreement for Mavacamten Rights in China and Asian Markets
Wednesday, October 25, 2023A biotechnology company focused on delivering innovative medicines to patients in China and other significant Asian markets has recently announced a major agreement with BristolMyers Squibb This agreement grants BMS exclusive rights to develop
Life Molecular Imaging and Sinotau Pharmaceutical Group Announce Regulatory Approval for Amyloid PET Imaging Radiopharmaceutical Neuraceq® in China
Wednesday, October 25, 2023Life Molecular Imaging and Sinotau Pharmaceutical Group are thrilled to announce that Neuraceq has obtained regulatory approval from the National Medical Products Administration in China
Mindray Expands Its Cardiac Biomarker Portfolio With State-of-the-art hs-cTnI and NT-proBNP Assays, Enhancing the Management of Cardiovascular Diseases
Tuesday, October 24, 2023Mindray a prominent global company specializing in medical devices and healthcare solutions has introduced new cardiac biomarkers including troponin I hscTnI and NTproBNP to enhance its diverse range of cardiac biomarkers
Samsung Biologics and Kurma Partners Establish Strategic Collaboration for Biologics Development and Manufacturing for Kurma's Portfolio Companies
Monday, October 23, 2023Samsung Biologics a global Contract Development and Manufacturing Organization has entered into a strategic partnership with Kurma Partners a European venture capital firm specializing in healthcare and biotechnology
